BioCentury
ARTICLE | Clinical News

Vibex QuickShot testosterone: Phase I/II started

September 23, 2013 7:00 AM UTC

Antares began an open-label, U.S. Phase I/II trial to compare weekly 50 and 100 mg doses of testosterone enanthate delivered using Antares' Vibex QuickShot vs. the standard of care of 200 mg testoster...